Please login to the form below

Lucid’s magic touch is recognised, winning both Communiqué Medical Education Consultancy of the Year and Communiqué Communications Consultancy of the Year 2018

Lucid’s pioneering and patient-centric approach to strategic medical communications was recognised yesterday as they scooped  a total of four awards. These included:
  • Excellence in Communications via Meetings for OptiMiSe – an innovative, meetings-based learning journey for clinical behaviour change among multiple sclerosis specialist nurses
  • Excellence in Professional Education Programmes for ‘Revolutionising management of hidradenitis suppurativa (HS) in Europe: Why? What? How?’ – a programme that has revolutionised the European HS community
This was topped off with two further wins including Communiqué Medical Education Consultancy of the Year 2018 and Communiqué Communications Consultancy of the Year 2018.

This continued success exemplifies Lucid’s ongoing and relentless commitment to improving patient outcomes, achieved through the tireless work of their highly talented teams.

Jan Steele, Lucid COO and co-founder, commented, “We love working with clients who share the same vision and ambitions as us. Our valued partnerships are integral to the delivery of these pioneering programmes that change behaviour and ultimately improve patient outcomes. To be awarded Communiqué Medical Education Consultancy of the Year 2018 and Communiqué Communications Consultancy of the Year 2018 is a fantastic achievement and reflects the commitment we have all made collectively to transform the lives of those we touch.”

29th June 2018

Share

Tags

Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

Address:
First Floor, Jubilee House
Third Avenue
Globe Park
Marlow
Bucks
SL7 1EY
UK

Latest content on this profile

My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: https://bit.ly/3jhlhUNOr contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited